RIM: Upgrades, Downgrades

Research in Motion is downgraded at Susquehanna to Negative; estimates cut at Credit Suisse, Goldman.
Author:
Publish date:

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Apollo

(APOL)

upgraded at Morgan Stanley from Equal-weight to Overweight. $60 price target. Relative valuation call, even though regulatory risks remain.

Autozone

(AZO) - Get Report

downgraded at Goldman from Neutral to Sell. Valuation call, based on a $213 price target.

Dress Barn

(DBRN)

rated new Overweight at Piper Jaffray. $30 price target. Company can exceed earnings expectations in the coming quarters, aided by merger synergies.

Ericsson

(ERIC) - Get Report

upgraded at Barclays. ERIC upgraded to Equal Weight from Underweight as many negative pressures should abate in 2H10 and 2011. Price target increased to $11 from $10.

Forest Oil

(FST)

upgraded at Barclays to Overweight from Equal Weight. Continued success in the Granite Wash & Nikanassin play could underpin strong production growth over next several years. Price target lifted from $38 to $40.

Carmax

(KMX) - Get Report

upgraded at Goldman from Sell to Neutral. $24 price target. Estimates also boosted, as used car sales are becoming more profitable.

Nokia

(NOK) - Get Report

upgraded at Barclays to Overweight from Equal Weight. Near term portfolio strengthening and potential long term strategic improvement from the CEO drives upgrade. Shares now seen reaching $13, up from $10.

NV Energy

(NVE)

downgraded at Citigroup from Buy to Hold. $14 price target. Valuation call, as the stock is up more than 10% over the past six months.

Opentable

(OPEN)

upgraded at Citigroup from Hold to Buy. $70 price target. Near-term trends are improving and Spotlight initiative should drive future growth.

PG&E

(PCG) - Get Report

downgraded at Credit Suisse to Neutral from Outperform. Last week's tragic gas pipeline explosion will create a wave of real and rhetorical political backlash for PCG. Price target fell to $45 from $50.

Public Service Enterprise

(PEG) - Get Report

downgraded at Barclays from Overweight to Equal Weight based on lack of near term catalysts, reduced earnings. Price target cut by a dollar to $35.

Penn Virginia

(PVA)

upgraded at Barclays to Overweight from Equal Weight. Production issues they faced during the second quarter have mostly been resolved. Price target trimmed to $25 from $30.

Research in Motion

(RIMM)

downgraded at Susquehanna to Negative. $37.50 price target. Checks indicate lower Touch sales and increased smartphone competition.

Research in Motion

(RIMM)

estimates sink at Credit Suisse. RIMM 2011 and 2012 EPs estimates trimmed to $5.63 and $6.09, respectively. Pressure on RIMM's enterprise position. Reiterate Outperform rating.

Research in Motion

(RIMM)

estimates reduced at Goldman through 2013. Competition is growing in the smartphone market. Sell rating.

Western Digital

(WDC) - Get Report

downgraded at Baird from Outperform to Neutral. $27 price target. Checks show lower consumer PC demand.

Werner Enterprises

(WERN) - Get Report

upgraded at Wells from Market Perform to Outperform. Company can deliver above-average growth.

ExxonMobil

(XOM) - Get Report

downgraded at Deutsche from Buy to Hold. $65 price target. Natural gas should be in fundamental oversupply for the next few years.

STOCK COMMENTS / EPS CHANGES

Applied Materials

(AMAT) - Get Report

target, estimates lower at Credit Suisse. AMAT 2010 and 2011 EPS estimates set at $0.82 and $0.97, respectively. Price target dropped to $12.25 from $13.50. Lower industry capex spending. Reiterate Neutral rating.

Atheros

(ATHR)

target reduced at FBR. Shares of ATHR now seen reaching $35. Company is leveraged to lower PC demand. Outperform rating.

Brooks Automation

(BRKS) - Get Report

price target cut at Credit Suisse to $6 from $8.40 on weaker industry capex estimates. Maintain Neutral rating.

CF Industries

(CF) - Get Report

numbers raised at Morgan Stanley. Shares of CF now seen reaching $115. Estimates also increased, given higher corn and lower gas prices. Overweight rating.

Cummins

(CMI) - Get Report

added to Conviction Buy List at Goldman. CMI was added to the Conviction Buy list. Estimates also boosted, given accelerating new product sales. Buy rating and new $104 price target.

Salesforce.com

(CRM) - Get Report

target increased at Kaufman to $140. New bookings growth is accelerating. Buy rating.

Entropic Communications

(ENTR) - Get Report

numbers higher at Barclays. ENTR 2010 and 2011 EPS estimates raised to 43 cents and 66 cents, respectively. Price target lifted to $12 from $9. Buoyant trends following recent industry checks. Maintain Overweight rating.

Health Management Associates

(HMA)

target trimmed at Barclays by a dollar to $10. Lower utilization may be significant headwind to hospital results in 2010. Maintain Overweight rating.

Lockheed Martin

(LMT) - Get Report

numbers cut at Deutsche Bank. Shares of LMT now seen reaching $82. Estimates also lowered, given another delay in the joint-strike fighter. Hold rating.

3M

(MMM) - Get Report

cut from Conviction Buy List at Goldman Sachs. Stock has outperformed and CMI offers better upside potential. $104 price target.

Navistar

(NAV) - Get Report

estimates, target cut at Goldman. Shares of NAV now seen reaching $49. Estimates also lowered, given weaker engine margins. Neutral rating.

Novellus Systems

(NVLS)

price target trimmed at Credit Suisse to $35 from $39.90 on potential near-term weakness in upstream/midstream tech. Reiterate Outperform rating.

PG&E

(PCG) - Get Report

estimates, target reduced at Morgan Stanley. PCG estimates were lowered through 2012. Accident in California will hurt earnings, on top of the potential liability. Equal-weight rating and new $46 price target.

Riverbed Technology

(RVBD)

target boosted at FBR. Shares of RVBD now seen reaching $46. Checks show strong demand across the board. Outperform rating.

Sandridge Energy

(SD) - Get Report

price target cut at Barclays to $6 from $10 on low gas prices. Maintain Overweight rating.

Tenet Healthcare

(THC) - Get Report

price target reduced at Barclays. THC price target fell to $6 from $8 on lower utilization rates in hospitals. Maintain Overweight rating.

This article was written by a staff member of TheStreet.